Freezing adversely affects measurement of vascular endothelial growth factor levels in human aqueous samples

Sankarathi Balaiya Sandeep Grover Ravi K Murthy Kakarla V ChalamDepartment of Ophthalmology, University of Florida College of Medicine, Jacksonville, FL, USAPurpose: Aqueous levels of vascular endothelial growth factor (VEGF) can be a surrogate marker of intraocular VEGF activity and a measure of ef...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sankarathi Balaiya, Sandeep Grover, Ravi K Murthy, et al
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/346c615c06b24816aa26263477b2b4ed
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:346c615c06b24816aa26263477b2b4ed
record_format dspace
spelling oai:doaj.org-article:346c615c06b24816aa26263477b2b4ed2021-12-02T07:42:39ZFreezing adversely affects measurement of vascular endothelial growth factor levels in human aqueous samples1177-54671177-5483https://doaj.org/article/346c615c06b24816aa26263477b2b4ed2011-01-01T00:00:00Zhttp://www.dovepress.com/freezing-adversely-affects-measurement-of-vascular-endothelial-growth--a6038https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Sankarathi Balaiya Sandeep Grover Ravi K Murthy Kakarla V ChalamDepartment of Ophthalmology, University of Florida College of Medicine, Jacksonville, FL, USAPurpose: Aqueous levels of vascular endothelial growth factor (VEGF) can be a surrogate marker of intraocular VEGF activity and a measure of efficacy of anti-VEGF treatment in a variety of vasoproliferative retinal disorders, including diabetic retinopathy, age-related macular degeneration, and central retinal vein occlusion. Measurement of the VEGF level may be adversely affected by premeasurement variables, such as freezing and delay, in sample analysis. We aim to evaluate the effect of storage and delayed measurement of human aqueous VEGF levels in these conditions.Methods: Aqueous samples collected from patients receiving intravitreal injection of bevacizumab for various retinal diseases were divided into two groups. In Group 1, the VEGF levels were analyzed on the same day; in Group 2, the VEGF levels were analyzed after 21 days of freezer storage (-80°C) using immunobead assay. Statistical comparison using a paired t-test was performed between the two groups.Results: Thirty-one aqueous humor samples were collected, and the VEGF concentration for fresh samples was 7.8 ± 5.9 pg/mL (mean ± SD) compared to 6.5 ± 6.0 pg/mL in frozen samples, resulting in a statistically significant difference (P = 0.03).Conclusions: Accurate measurement of the VEGF level is a vital component of clinical decision-making. Delayed analysis of VEGF levels in aqueous samples may result in significant sample degradation and lower levels of measured VEGF.Keywords: VEGF level, aqueous humor, immunobead assay, VEGF storage Sankarathi BalaiyaSandeep GroverRavi K Murthyet alDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 81-85 (2011)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Sankarathi Balaiya
Sandeep Grover
Ravi K Murthy
et al
Freezing adversely affects measurement of vascular endothelial growth factor levels in human aqueous samples
description Sankarathi Balaiya Sandeep Grover Ravi K Murthy Kakarla V ChalamDepartment of Ophthalmology, University of Florida College of Medicine, Jacksonville, FL, USAPurpose: Aqueous levels of vascular endothelial growth factor (VEGF) can be a surrogate marker of intraocular VEGF activity and a measure of efficacy of anti-VEGF treatment in a variety of vasoproliferative retinal disorders, including diabetic retinopathy, age-related macular degeneration, and central retinal vein occlusion. Measurement of the VEGF level may be adversely affected by premeasurement variables, such as freezing and delay, in sample analysis. We aim to evaluate the effect of storage and delayed measurement of human aqueous VEGF levels in these conditions.Methods: Aqueous samples collected from patients receiving intravitreal injection of bevacizumab for various retinal diseases were divided into two groups. In Group 1, the VEGF levels were analyzed on the same day; in Group 2, the VEGF levels were analyzed after 21 days of freezer storage (-80°C) using immunobead assay. Statistical comparison using a paired t-test was performed between the two groups.Results: Thirty-one aqueous humor samples were collected, and the VEGF concentration for fresh samples was 7.8 ± 5.9 pg/mL (mean ± SD) compared to 6.5 ± 6.0 pg/mL in frozen samples, resulting in a statistically significant difference (P = 0.03).Conclusions: Accurate measurement of the VEGF level is a vital component of clinical decision-making. Delayed analysis of VEGF levels in aqueous samples may result in significant sample degradation and lower levels of measured VEGF.Keywords: VEGF level, aqueous humor, immunobead assay, VEGF storage
format article
author Sankarathi Balaiya
Sandeep Grover
Ravi K Murthy
et al
author_facet Sankarathi Balaiya
Sandeep Grover
Ravi K Murthy
et al
author_sort Sankarathi Balaiya
title Freezing adversely affects measurement of vascular endothelial growth factor levels in human aqueous samples
title_short Freezing adversely affects measurement of vascular endothelial growth factor levels in human aqueous samples
title_full Freezing adversely affects measurement of vascular endothelial growth factor levels in human aqueous samples
title_fullStr Freezing adversely affects measurement of vascular endothelial growth factor levels in human aqueous samples
title_full_unstemmed Freezing adversely affects measurement of vascular endothelial growth factor levels in human aqueous samples
title_sort freezing adversely affects measurement of vascular endothelial growth factor levels in human aqueous samples
publisher Dove Medical Press
publishDate 2011
url https://doaj.org/article/346c615c06b24816aa26263477b2b4ed
work_keys_str_mv AT sankarathibalaiya freezingadverselyaffectsmeasurementofvascularendothelialgrowthfactorlevelsinhumanaqueoussamples
AT sandeepgrover freezingadverselyaffectsmeasurementofvascularendothelialgrowthfactorlevelsinhumanaqueoussamples
AT ravikmurthy freezingadverselyaffectsmeasurementofvascularendothelialgrowthfactorlevelsinhumanaqueoussamples
AT etal freezingadverselyaffectsmeasurementofvascularendothelialgrowthfactorlevelsinhumanaqueoussamples
_version_ 1718399212712886272